Results 221 to 230 of about 145,467 (273)

Integrative proteomic analysis provides novel therapeutic insights for etiological subtypes of diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 12, Page 6894-6904, December 2025.
Abstract Aims Type 2 diabetes (T2D) is a highly heterogeneous disease characterised by subtypes with variations in aetiology, disease progression, and risk of complications. However, potential drug targets for these subtypes have not been explored. This study aims to investigate potential drug targets by integrating proteomics.
Jiahe Wei   +8 more
wiley   +1 more source

Impact of Direct Oral Anticoagulant Uptake on Hospitalizations for Stroke/Transient Ischemic Attack, Intracranial Hemorrhage, and Gastrointestinal Bleeding in Individuals With Atrial Fibrillation: A Population‐Based Study

open access: yesFundamental &Clinical Pharmacology, Volume 39, Issue 6, December 2025.
ABSTRACT Background Direct‐acting oral anticoagulants (DOACs) have largely replaced warfarin for stroke prevention in patients with atrial fibrillation, yet their population‐level impact on health outcomes and costs remains unclear. We examined whether the widespread uptake of DOACs was associated with changes in hospitalization rates and costs for ...
Tony Antoniou   +4 more
wiley   +1 more source

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity

open access: yesObesity Reviews, Volume 26, Issue 12, December 2025.
ABSTRACT Introduction Although the physiologic alterations seen in obesity often affect the pharmacokinetics and pharmacodynamics of drugs, most clinical trials do not consider these aspects specifically for this population. To date, there is no list of potentially inappropriate medications for patients living with obesity. The aim of this study was to
Sarah Berdot   +17 more
wiley   +1 more source

Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus

open access: yesJournal of Thrombosis and Thrombolysis, 2019
M. E. Bass   +6 more
semanticscholar   +1 more source

Trends and Outcomes of Anticoagulation for Post‐Operative Atrial Fibrillation After Coronary Artery Bypass Graft

open access: yesPacing and Clinical Electrophysiology, Volume 48, Issue 12, Page 1444-1450, December 2025.
ABSTRACT Background The benefit of oral anticoagulation (OAC) in patients with new‐onset postoperative atrial fibrillation (POAF) after coronary bypass grafting remains uncertain. The 2023 American Heart Association (AHA) and the American College of Cardiology (ACC) guidelines recommend 60 days of anticoagulation for POAF, whereas management was ...
Daniel S. Cheah   +4 more
wiley   +1 more source

Elderly Medical Patients' Experience of an Acute Readmission to the Emergency Department—An Interpretative Phenomenological Analysis

open access: yesScandinavian Journal of Caring Sciences, Volume 39, Issue 4, December 2025.
ABSTRACT Aims and Objectives To explore the experiences of elderly medical patients shortly after an unplanned emergency department readmission and the perceived value of health care encounters. Background Elderly medical patients are often frail, have multiple health issues and are at risk for (re)admissions, loss of function, morbidity, and mortality.
Sara Levi Hemmingsen   +4 more
wiley   +1 more source

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

open access: yesNew England Journal of Medicine, 2005
M. Chimowitz   +12 more
semanticscholar   +1 more source

Safety evaluation of jagua (genipin‐glycine) blue as a food additive

open access: yesEFSA Journal, Volume 23, Issue 12, December 2025.
Abstract The EFSA Panel on Food Additives and Flavourings (FAF Panel) provides a scientific opinion on the safety of jagua (genipin‐glycine) blue as a new food additive. Jagua (genipin‐glycine) blue is obtained by water extraction of the ground pulp of the peeled, unripe fruits of Genipa americana L.
EFSA Panel on Food Additives and Flavourings (FAF)   +29 more
wiley   +1 more source

Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation

open access: yesJournal of the American Medical Association (JAMA), 2017
W. Lau   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy